526445 — Indrayani Biotech Income Statement
0.000.00%
Last trade - 00:00- IN₹683.04m
- IN₹1.56bn
- IN₹1.66bn
Annual income statement for Indrayani Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 211 | 616 | 1,629 | 1,662 |
| Cost of Revenue | ||||
| Gross Profit | 49.8 | 202 | 607 | 624 |
| Selling / General / Administrative Expenses | ||||
| Depreciation and Amortization | ||||
| Unusual Expense / Income | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 306 | 555 | 1,496 | 1,464 |
| Operating Profit | -95.1 | 61.2 | 134 | 199 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -112 | 44.6 | 123 | 110 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -112 | 44.6 | 119 | 104 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -112 | 44.6 | 119 | 104 |
| Adjustments to Net Income | ||||
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -112 | 44.4 | 119 | 104 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -2.08 | 1.3 | 2.86 | 2.68 |
| Dividends per Share |